惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

The Last Watchdog
The Last Watchdog
C
Cyber Attacks, Cyber Crime and Cyber Security
L
LINUX DO - 热门话题
G
GRAHAM CLULEY
S
Schneier on Security
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
S
SegmentFault 最新的问题
IT之家
IT之家
阮一峰的网络日志
阮一峰的网络日志
Recorded Future
Recorded Future
I
Intezer
云风的 BLOG
云风的 BLOG
博客园 - Franky
月光博客
月光博客
大猫的无限游戏
大猫的无限游戏
T
Tenable Blog
The Hacker News
The Hacker News
T
The Blog of Author Tim Ferriss
Attack and Defense Labs
Attack and Defense Labs
D
DataBreaches.Net
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
N
News and Events Feed by Topic
有赞技术团队
有赞技术团队
Exploit-DB.com RSS Feed
Exploit-DB.com RSS Feed
N
News and Events Feed by Topic
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
S
Secure Thoughts
The Register - Security
The Register - Security
B
Blog
Security Archives - TechRepublic
Security Archives - TechRepublic
The Cloudflare Blog
Webroot Blog
Webroot Blog
W
WeLiveSecurity
H
Heimdal Security Blog
博客园 - 三生石上(FineUI控件)
V
Vulnerabilities – Threatpost
G
Google Developers Blog
O
OpenAI News
V
V2EX
罗磊的独立博客
博客园_首页
N
News | PayPal Newsroom
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
CTFtime.org: upcoming CTF events
CTFtime.org: upcoming CTF events
TaoSecurity Blog
TaoSecurity Blog
Cloudbric
Cloudbric
H
Hacker News: Front Page
博客园 - 叶小钗
T
Tor Project blog
AI
AI

Forbes - Healthcare

How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
Grandstanding At Hearings In Congress Doesn’t Solve Healthcare Issues
Joshua P. Cohen · 2026-05-09 · via Forbes - Healthcare
Medical Expenses Insurance Cost Concept

Hearings on healthcare on Capitol Hill are increasingly dominated by grandstanding on both sides of the aisle. The heavily politicized nature of these events doesn't lend itself to constructive problem-solving.

getty

Hearings on healthcare on Capitol Hill often devolve into partisan grandstanding on both sides of the aisle. The heavily politicized nature of these events usually doesn’t lend itself to constructive problem-solving.

At a January hearing, for instance, bickering politicians on both sides of the aisle agreed on one thing. painting a picture of bogeymen CEOs as healthcare villains, if you will. The Washington Post summed it up as follows:

“Despite partisan divide over solutions, Republicans and Democrats join in berating health insurance executives for rising premiums, denial of care and their multimillion-dollar compensation.”

Designed as oversight, House and Senate hearings have brought in pharmacy benefit manager, insurer, drug company and hospital executives to testify. Undoubtedly, holding these individuals accountable for their actions and decision-making is an important function of these sessions. But lawmakers often appear more focused on badgering witnesses (as if they’re on trial as defendants) or repeating often diametrically opposed political positions than attempting to find bipartisan policy solutions.

This may be great for politically charged soundbites, but it begs the question, what’s the point of these hearings? At a high level, lawmakers may want to have as a backdrop to each hearing the objectives laid out in the Triple Aim framework developed by the not-for-profit Institute for Healthcare Improvement: Improve population health, enhance patient experience and reduce healthcare cost growth.

It’s no secret that absolute and per capita healthcare costs are very high in the United States. This wouldn’t be as much of a problem if the system produced correspondingly excellent health outcomes. But overall, it doesn’t. The U.S. ranks at or near the bottom among peer nations on measures such as reduction of avoidable mortality.

The disconnection between the large amount of money the U.S. spends on healthcare and the country’s subpar overall outcomes isn’t a partisan issue. Nor are the high costs of healthcare for many patients owing to a particular measure pushed by one party or the other. And it’s not due singularly to stakeholder actions, however problematic certain behaviors may seem. Rather, it’s because of systemwide dysfunction that can’t be resolved by finger-pointing or pinning the blame on one group or another.

Accordingly, reforms are needed. But they’re not coming in the form of a teardown of an existing pillar such as the Affordable Care Act. It’s the law of the land. And it’s comparatively popular among constituents.

However, at a January hearing in which health insurance executives testified, Republicans declared that the ACA was the source of trouble as it was causing rising costs. And in a tit for tat, Democrats defended the ACA and blamed Republicans for voting to end the extended ACA subsidies for millions of people.

KFF conducted a survey this spring of Americans who were enrolled on the ACA marketplace exchange in 2025. Since Congress failed to extend enhanced federal subsidies that had made ACA coverage affordable for many in recent years, the survey found that premiums went up for the vast majority of respondents and often considerably. And many people reported struggles with paying medical bills.

Yet lawmakers haven’t budged from their initial positions on the ACA. Compromise doesn’t appear to be on the table. It’s almost as if facts on the ground don’t matter, namely that constituents nationwide are hurting financially with millions ditching healthcare coverage altogether due to costs and now simply hoping for the best, that is, not to get sick.

Illustrations of Congressional inertia and a tendency to resort to predetermined talking points aren’t confined to politically sensitive topics such as the ACA. Even during somewhat dry fact-finding sessions political campaign themes are brought up or even information with no apparent relevance to the topic at hand.

For instance, at a House hearing last month on hospitals, health systems and rising costs, Democrat John Larson (D-Conn.) introduced Medicare for All as a supposed elixir. Needless to say, such a radical change isn’t imminent. There isn’t nearly sufficient support for Medicare for All in Congress. Why then even bring it up in a meeting with hospital executives?

Meanwhile, Republican Jason Smith (R-Mo.) talked about hospital margins being greater than those achieved by Delta Airlines, Target and Disney, all three companies in totally unrelated industries with vastly different cost structures.

It’s refreshing, however, that hospitals are getting scrutiny in Congress. After all, hospital costs account for the greatest share of overall healthcare expenditures, which translates into ever-increasing premiums for consumers as insurers pass on increased medical service spending. Increasing prices of procedures, labor costs and myriad facility fees are helping drive up spending on hospital inpatient care, which for several decades has risen about twice the rate of inflation, outpacing physician and outpatient services as well as prescription drugs. An increase in uncompensated care due to the increasing numbers of un- and underinsured also impacts hospitals negatively. Furthermore, health system mergers have eliminated many community hospitals. Meanwhile, the emergence of mega conglomerates hasn’t curbed costs, or led to an improvement in quality of care.

But as legislators grilled hospital executives, at times they appeared to be talking at cross purposes.

Nevertheless, this particular hearing revealed the potential for a mutual understanding on a few issues. Lawmakers from both parties agreed on the problems at hand of high hospital expenditures and patient access barriers such as prior authorization. They also identified several areas of possible bipartisan overlap. This includes pursuit of a site-neutral payment system in which Medicare reimbursement amounts would be standardized, regardless of whether a service is delivered in a hospital outpatient department, independent physician’s office or ambulatory surgery center.

Several areas of common ground notwithstanding, the session on hospital care and costs offered only limited room for compromise or even approaching most objective issues without a political lens. And this seems peculiar to observers. Not just at this hearing, but other meetings on healthcare, too.

The financial pressures associated with healthcare affect practically every American household, in the form of cuts in coverage, rising insurance premiums, out-of-pocket costs for things like prescription drugs or emergency room visits. This ought to be front and center at every hearing. After all, lawmakers represent the American public, both in districts in their home states and at the national level.

Instead, the hearings tend to function as venues for adversarial political messaging and electoral gain rather than legislative consensus-building to identify and eventually solve the large problems affecting U.S. patients. Waging political battles doesn’t address the constituents’ burdens stemming from the healthcare system, financial and otherwise.